Trials / Completed
CompletedNCT06523686
Lateral Ridge Augmentation Using Two Graft Combination and a Cross-linked Collagen Membrane
Lateral Ridge Augmentation Using Autogenous-xenogeneic or Allogeneic-xenogeneic Graft Mix With a Cross-linked Collagen Membrane: a Randomized Pilot Clinical Trial
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- Saint-Joseph University · Academic / Other
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
To treat resorbed alveolar ridges, many surgical procedures are available in the literature such as ridge splitting, distraction osteogenesis, block grafting techniques and guided bone regeneration, which is the most documented technique. Various grafting materials are available but there is a lack of evidence on the superiority of a material or a combination of materials.
Detailed description
Bone width at the implant site is an important prerequisite for a predictable and long-term prognosis in implant dentistry. Different types of membranes and bone grafts are used in the GBR procedure. However, there is a lack of studies in the literature about the combination allograft/xenograft. The aim of the present trial is to compare two different bone graft combinations (autogenous-xenogeneic and allogeneic-xenogeneic) covered with a cross-linked collagen membrane in a horizontal alveolar ridge augmentation (without simultaneous implant placement).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Guided bone regeneration | Compare the linear and volumetric bone width changes, clinically and radiographically, between two different bone graft combinations (autogenous-xenogeneic and allogeneic-xenogeneic) covered with a cross-linked collagen membrane in a horizontal GBR. |
Timeline
- Start date
- 2023-01-09
- Primary completion
- 2024-06-10
- Completion
- 2024-07-10
- First posted
- 2024-07-26
- Last updated
- 2024-07-26
Locations
1 site across 1 country: Lebanon
Source: ClinicalTrials.gov record NCT06523686. Inclusion in this directory is not an endorsement.